BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Enel Chile
ENIC
$6.1B
| $3.82M | ﹤0.01% |
1,583,353
+137,227
| +9% | +$351K |
|
|
DRD
3927
DRDGold
DRD
$2.06B
| $3.8M | ﹤0.01% |
469,389
-3,707
| -0.8% | -$35.8K |
|
|
PLL
3928
DELISTED
Piedmont Lithium
PLL
| $3.79M | ﹤0.01% |
69,522
-2,217
| -3% | -$129K |
|
|
GARP
3929
iShares MSCI USA Quality GARP ETF
GARP
$2.87B
| $3.78M | ﹤0.01% |
105,000
| – | – |
|
|
IMPX
3930
DELISTED
AEA-Bridges Impact Corp
IMPX
| $3.77M | ﹤0.01% |
385,790
+25,359
| +7% | +$247K |
|
3931
Harrow
HROW
$1.46B
| $3.77M | ﹤0.01% |
414,886
+1,021
| +0.2% | +$9.24K |
|
3932
iShares Investment Grade Systematic Bond ETF
IGEB
$1.51B
| $3.77M | ﹤0.01% |
70,124
-70,909
| -50% | -$3.86M |
|
3933
Capital Southwest
CSWC
$1.61B
| $3.76M | ﹤0.01% |
149,306
+21,730
| +17% | +$566K |
|
|
MSB
3934
Mesabi Trust
MSB
$305M
| $3.75M | ﹤0.01% |
126,242
+25,386
| +25% | +$848K |
|
3935
Xeris Biopharma Holdings
XERS
$1.52B
| $3.74M | ﹤0.01% |
1,525,808
-158,358
| -9% | -$460K |
|
3936
Crescent Capital BDC
CCAP
$417M
| $3.72M | ﹤0.01% |
+194,660
| New | +$3.66M |
|
|
TBIO
3937
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $3.71M | ﹤0.01% |
18,526
+7,417
| +67% | +$1.88M |
|
|
SA
3938
Seabridge Gold
SA
$3.46B
| $3.7M | ﹤0.01% |
239,624
+25,618
| +12% | +$444K |
|
3939
Sprinklr
CXM
$1.65B
| $3.64M | ﹤0.01% |
+208,066
| New | +$3.88M |
|
|
JPXN
3940
iShares JPX-Nikkei 400 ETF
JPXN
$142M
| $3.64M | ﹤0.01% |
48,466
-158
| -0.3% | -$11.7K |
|
|
KL
3941
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $3.61M | ﹤0.01% |
86,775
-1,766
| -2% | -$71.7K |
|
3942
Genasys
GNSS
$77.9M
| $3.6M | ﹤0.01% |
694,013
-7,117
| -1% | -$38.3K |
|
3943
TriplePoint Venture Growth BDC
TPVG
$221M
| $3.58M | ﹤0.01% |
226,209
+40,884
| +22% | +$640K |
|
|
BECO
3944
DELISTED
BlackRock Future Climate and Sustainable Economy ETF
BECO
| $3.58M | ﹤0.01% |
+150,000
| New | +$3.79M |
|
|
ZYNE
3945
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $3.57M | ﹤0.01% |
841,153
+66,889
| +9% | +$298K |
|
3946
Pixelworks
PXLW
$45.7M
| $3.56M | ﹤0.01% |
62,170
+10,274
| +20% | +$521K |
|
3947
DHI Group
DHX
$174M
| $3.56M | ﹤0.01% |
748,737
-19,999
| -3% | -$78.5K |
|
3948
Riley Exploration Permian
REPX
$786M
| $3.56M | ﹤0.01% |
151,502
-5,834
| -4% | -$124K |
|
3949
Climb Global Solutions
CLMB
$532M
| $3.54M | ﹤0.01% |
526,612
+66,016
| +14% | +$448K |
|
3950
Matinas BioPharma
MTNB
$1.49M
| $3.54M | ﹤0.01% |
54,476
+446
| +0.8% | +$19.2K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.